₩319000.00
₩-8000.00 (-2.45%)
End-of-day quote: 05/09/2024
KOSE:A128940
Hanmi Pharm. Annual Report
Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
₩1.49T | ₩1.33T | ₩1.20T | ₩1.08T | ₩1.11T | ₩1.02T | ₩916.59B | ₩882.72B | ₩1.32T | ₩761.28B | ₩730.13B | ₩606.19B | ₩674.76B | |
GM % | Gross Margin % |
|
55.62% | 53.96% | 52.59% | 54.00% | 56.79% | 53.24% | 56.56% | 52.21% | 69.74% | 55.45% | 56.99% | 55.10% | 56.79% | |
OM | Operating Margin |
|
15.08% | 11.56% | 10.42% | 4.55% | 9.33% | 8.23% | 8.96% | 3.03% | 16.08% | 4.53% | 8.48% | 3.50% | -1.13% | |
EPS | Earnings Per Share |
|
₩0.00 | ₩11.52k | ₩7.99k | ₩5.27k | ₩939.50 | ₩4.17k | ₩1.99k | ₩4.87k | ₩1.95k | ₩12.07k | ₩2.94k | ₩4.04k | ₩118.51 | ₩-473.79 |
Div. | Dividends |
|
₩488.81 | ₩490.20 | ₩480.58 | ₩471.16 | ₩461.92 | ₩452.87 | ₩443.99 | ₩1.74k | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩410.14 | |
PR % | Payout Ratio % |
|
4.24% | 6.13% | 9.12% | 50.15% | 11.08% | 22.72% | 9.12% | 89.21% | 0.00% | 0.00% | 0.00% | 0.00% | -86.57% | |
Sha. | Shares |
|
12.69m | 12.45m | 12.22m | 12.24m | 11.77m | 11.55m | 11.56m | 11.04m | 11.59m | 11.27m | 10.05m | 10.06m | 10.07m | |
OCF | Operating Cash Flow |
|
₩216.54B | ₩162.27B | ₩201.92B | ₩151.53B | ₩12.45B | ₩25.98B | ₩-62905.20M | ₩412.97B | ₩101.71B | ₩-32819.71M | ₩85.99B | ₩61.30B | ₩37.89B | |
FCF | Free Cash Flow |
|
₩181.77B | ₩131.89B | ₩181.97B | ₩109.72B | ₩-153684.70M | ₩-156285.75M | ₩-309959.08M | ₩212.71B | ₩-19352.73M | ₩-101998.70M | ₩59.42B | ₩41.75B | ₩-497.01M | |
FCFS | Free Cash Flow Per Share |
|
₩13.63k | ₩8.96k | ₩13.72k | ₩7.66k | ₩-14060.18 | ₩-15706.98 | ₩-28900.64 | ₩17.49k | ₩-3024.52 | ₩-9608.64 | ₩4.89k | ₩3.08k | ₩-1223.85 |